MICKAELA KELLY: Open Payments
NPI 1881267979 · SYKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 90 payments from 22 companies in 2025. Trend: 2023 $2,086 · 2024 $1,961 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $261 |
| PFIZER INC. | 9 | $175 |
| Lilly USA, LLC | 9 | $171 |
| Astellas Pharma US Inc | 5 | $147 |
| Amgen Inc. | 9 | $141 |
| Novo Nordisk Inc | 6 | $115 |
| Merck Sharp & Dohme LLC | 3 | $83 |
| Lundbeck LLC | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| Bausch Health US, LLC | 3 | $74 |
Products named: Veozah, MOUNJARO, NURTEC ODT, QULIPTA, JARDIANCE, VRAYLAR, CAPVAXIVE, APLENZIN.
Industry payments across MD — which companies pay providers there.
